{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:31:33Z","timestamp":1790022693246,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012323","name":"CSIR - Indian Institute of Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019720","name":"GlaxoSmithKline Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001134","name":"Australia-India Strategic Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["GAP-375"],"award-info":[{"award-number":["GAP-375"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/Indo-Aus\/10\/22\/2016"],"award-info":[{"award-number":["BT\/Indo-Aus\/10\/22\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116256","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T02:23:53Z","timestamp":1709000633000},"page":"116256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani"],"prefix":"10.1016","volume":"269","author":[{"given":"Nirmal","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayasree","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Goon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnu Prasad","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnali","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Sarif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purbita","family":"Bandopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasis","family":"Barik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suravi","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylene","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Baell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"McConville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipyaman","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-1795","authenticated-orcid":false,"given":"Arindam","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116256_bib1","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2024.116256_bib2","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Fabiana","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2024.116256_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2024.116256_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116256_bib5","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1021\/jm9004835","article-title":"Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against trypanosoma and leishmania","volume":"52","author":"Cavalli","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pharmthera.2011.11.008","article-title":"Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections","volume":"133","author":"Geurts","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.116256_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2010.09.006","article-title":"Diagnosis of visceral leishmaniasis","volume":"105","author":"Srivastava","year":"2011","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116256_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ejmech.2024.116256_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2022.114577","article-title":"Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani","volume":"240","author":"McNamara","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2915.2012.01034.x","article-title":"Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern","volume":"27","author":"Maroli","year":"2013","journal-title":"Med. Vet. Entomol."},{"key":"10.1016\/j.ejmech.2024.116256_bib11","series-title":"Visceral Leishmaniasis Detection Using Deep Learning Techniques and Multiple Color Space Bands BT - Intelligent Systems Design and Applications","first-page":"492","author":"Borges","year":"2023"},{"key":"10.1016\/j.ejmech.2024.116256_bib12","first-page":"1078","article-title":"Awareness and preventive practice on kala-azar among the community people of morang, Nepal","volume":"3","author":"Poudel","year":"2023","journal-title":"Int. J. Med. Sci. Clin. Res. Stud."},{"key":"10.1016\/j.ejmech.2024.116256_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2024.116256_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116256_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","article-title":"Combating tropical infectious diseases: report of the disease control priorities in developing countries project","volume":"38","author":"Hotez","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116256_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1039\/D1MD00362C","article-title":"Current leishmaniasis drug discovery","volume":"13","author":"Pinheiro","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2024.116256_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S0031182016002031","article-title":"Evaluating drug resistance in visceral leishmaniasis: the challenges","volume":"145","author":"Hendrickx","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2024.116256_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/TCRM.S30139","article-title":"Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)","volume":"8","author":"Wiwanitkit","year":"2012","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejmech.2024.116256_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116256_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116256_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116256_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpddr.2019.05.002","article-title":"Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease","volume":"10","author":"Roquero","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116256_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpddr.2018.09.006","article-title":"Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis","volume":"8","author":"Alc\u00e2ntara","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116256_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmdc.202300069","article-title":"Mitigating hERG liability of toll-like receptor 9 and 7 antagonists through structure-based design","volume":"18","author":"Das","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116256_bib26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3987\/COM-12-12466","article-title":"Facile and efficient cyclization of anthranilonitrile to 2, 4-dichloroquinazoline by bis (trichloromethyl) carbonate and catalytic amount triphenylphosphine oxide","volume":"85","author":"Zhong","year":"2012","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2024.116256_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijantimicag.2019.07.013","article-title":"Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds","volume":"54","author":"Corman","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2024.116256_bib28","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2018.09.058","article-title":"Activity-guided development of potent and selective toll-like receptor 9 antagonists","volume":"159","author":"Paul","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2013.12.033","article-title":"N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism","volume":"74","author":"Renard","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib31","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.bmcl.2016.03.043","article-title":"Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors","volume":"26","author":"Dinges","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116256_bib32","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1021\/acs.jmedchem.7b00328","article-title":"Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies","volume":"60","author":"Yeung","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/C9MD00396G","article-title":"Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds","volume":"11","author":"Lazzara","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00705-017-3641-5","article-title":"Pharmacophoric characteristics of dengue virus NS2B\/NS3pro inhibitors: a systematic review of the most promising compounds","volume":"163","author":"Leonel","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejmech.2024.116256_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15060717","article-title":"The diverse biological activity of recently synthesized nitro compounds","volume":"15","author":"Noriega","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116256_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116256_bib37","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib38","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/jm0306529","article-title":"Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat","volume":"47","author":"Lu","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2024.116256_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.actatropica.2005.03.004","article-title":"Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase","volume":"94","author":"Vergnes","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2024.116256_bib41","first-page":"27","article-title":"Nishi, Visceral leishmaniasis: experimental models for drug discovery","volume":"133","author":"Gupta","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2024.116256_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/adt.2015.652","article-title":"High-content assay for measuring intracellular growth of leishmania in human macrophages","volume":"13","author":"Dagley","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2024.116256_bib43","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1021\/acs.jmedchem.8b01938","article-title":"Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 Poison with potent anticancer activity","volume":"62","author":"Kundu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib44","doi-asserted-by":"crossref","first-page":"11607","DOI":"10.1021\/acs.jmedchem.2c00386","article-title":"Development, optimization, and in vivo validation of new imidazopyridine chemotypes as dual TLR7\/TLR9 antagonists through activity-directed sequential incorporation of relevant structural subunits","volume":"65","author":"Das","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib45","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1021\/acs.jmedchem.0c00011","article-title":"A chemical switch for transforming a purine agonist for toll-like receptor 7 to a clinically relevant antagonist","volume":"63","author":"Mukherjee","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116256_bib46","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1021\/acs.jmedchem.1c00532","article-title":"Systematic optimization of potent and orally bioavailable purine scaffold as a dual inhibitor of toll-like receptors 7 and 9","volume":"64","author":"Kundu","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:06:09Z","timestamp":1777529169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424001363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S0223523424001363"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116256","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116256"}}